Last Update 25 Jun 26
IRI: New AI Observability Offerings Will Support Future Upside
Analysts have kept their A$0.36 price target for Integrated Research unchanged, citing only very small adjustments to inputs such as the discount rate, long run revenue growth, profit margin and future P/E assumptions.
What’s in the News for Integrated Research
- Integrated Research announced Iris for Card Payments, an AI powered assistant built on the Prognosis observability platform that uses natural language prompts to provide real time card payments insights. It is designed to help payments teams detect issues earlier and understand their impact faster. Source: Company key developments.
- Iris for Card Payments is described as supporting card payments environments where transaction volumes can spike and dependencies multiply. It includes built in IR correlation logic intended to explain why issues occur and to make deep card payments expertise more accessible to teams. Source: Company key developments.
- Integrated Research reported that its UC&C observability solution, Collaborate, now supports NICE CXone within Prognosis 13.3, aggregating telemetry from CXone, bring your own carrier infrastructure and multi vendor UC platforms into a single intelligence layer for monitoring customer interactions. Source: Company key developments.
- Collaborate with Prognosis 13.3 is described as offering unified CDR search and AI powered search across CXone, UC platforms and SBCs, along with real time and historical dashboards, customer journey analytics and threshold based alerting for operations and IT teams. Source: Company key developments.
- Integrated Research announced Iris for Nonstop, extending its conversational AI layer to HPE Nonstop environments so IT and business teams can ask natural language questions about system health, performance and capacity. It is intended to support incident resolution and capacity planning across mission critical workloads. Source: Company key developments.
Valuation Changes for Integrated Research
- Fair Value: The A$0.36 fair value estimate remains unchanged, indicating no revision to the central valuation point.
- Discount Rate: The discount rate has been adjusted slightly lower from 8.46% to 8.43%, reflecting a small change in the rate used to assess future cash flows.
- Revenue Growth: The forecast revenue growth assumption is essentially unchanged at about 5.67%, with only a minor numerical refinement.
- Net Profit Margin: The net profit margin assumption remains effectively steady at about 7.71%, with only a small rounding adjustment.
- Future P/E: The future P/E multiple assumption has been trimmed marginally from 13.78x to 13.77x, representing a very small change in the valuation multiple applied.
Key Takeaways
- Growing demand for real-time observability and unified communication monitoring is boosting recurring revenue opportunities and strengthening client retention.
- Strategic product innovation and a shift to subscription models are expected to improve revenue stability and support long-term growth.
- Revenue instability, declining core segment performance, and execution risks from product transitions threaten growth and margins amid intense industry competition and shifting customer preferences.
Catalysts
About Integrated Research- Designs, develops, implements, and sells software for business-critical computing, unified communication, and payment networks.
- Acceleration of digital transformation and cloud adoption continues to increase the complexity and criticality of IT ecosystems, which is expanding demand for real-time observability and performance analytics platforms like those of Integrated Research-supporting future revenue growth as organizations require robust monitoring across both hybrid and cloud environments.
- Widespread proliferation of hybrid and remote work is driving growing reliance on unified communications and collaboration platforms, directly underpinning the need for IR's real-time monitoring and diagnostic solutions, especially as enterprise customers focus on IT resilience and user experience-providing a tailwind for both client retention and upsell opportunities that will benefit recurring revenues.
- The company's strategic pivot to product-led growth and accelerated R&D investment-highlighted by the release of new cloud-hosted solutions (Prognosis Elevate), AI-powered analytics (Iris), and domain-specific products (High Value Payments)-is positioning IR to open new revenue streams and improve cross-sell/upsell, supporting a structural improvement in long-term growth.
- Transition towards subscription-based and consumption pricing models (akin to SaaS), as well as increasing adoption of cloud-native delivery, is expected to increase both revenue visibility and margin stability, smoothing earnings and reducing cyclicality traditionally associated with one-time license deals.
- Strong balance sheet (net cash position and no debt) ensures IR can continue to invest heavily in product innovation and commercial expansion, increasing the probability of capturing market share as clients migrate to modern performance management and compliance-driven solutions-potentially leading to margin expansion and sustained earnings growth once the investment phase moderates.
Integrated Research Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Integrated Research's revenue will grow by 5.7% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 10.7% today to 7.7% in 3 years time.
- Analysts expect earnings to reach A$6.2 million (and earnings per share of A$0.04) by about June 2029, down from A$7.3 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.8x on those 2029 earnings, up from 7.0x today. This future PE is lower than the current PE for the AU Software industry at 23.4x.
- Analysts expect the number of shares outstanding to grow by 1.07% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.43%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- The company's historical reliance on contract renewals-subject to annual fluctuation-remains unresolved, as new client and expansion revenues are still insufficient to offset persistent churn, risking revenue instability and potential ongoing declines in top-line growth.
- Despite the launch of new products and product-led growth initiatives, management expects profits and potentially EBITDA margins to decline for two to three years as investment in R&D and commercialization accelerates, directly impacting near
- and medium-term earnings and net margins.
- The core Collaborate segment is experiencing double-digit revenue decline (-10% YoY), while market commentary notes continued client trends toward shortening contract durations and cost-efficiency, suggesting ongoing vulnerability to customer loss and downward pressure on recurring revenues.
- Increased investment in new product launches (including cloud and AI products) carries significant execution risk; failure to successfully transition offerings to cloud/SaaS and scale new revenue streams could result in shrinking net margins and muted revenue growth while fixed costs remain high.
- Industry-wide shifts-including the growing dominance of integrated, all-in-one observability solutions from large tech providers and increased commoditization-may threaten Integrated Research's relevance as a niche provider, potentially leading to persistent margin erosion and earnings pressure.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of A$0.36 for Integrated Research based on their expectations of its future earnings growth, profit margins and other risk factors.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be A$80.0 million, earnings will come to A$6.2 million, and it would be trading on a PE ratio of 13.8x, assuming you use a discount rate of 8.4%.
- Given the current share price of A$0.28, the analyst price target of A$0.36 is 22.2% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Integrated Research?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.